TL;DR
This study demonstrates that an Enhanced Recovery After Surgery (ERAS) program significantly reduces hospital stay and costs, while also decreasing complications, for patients undergoing laparoscopic liver resection compared to traditional care. This suggests ERAS is a safe and effective approach for this specific surgical procedure.
What Problem Does This Paper Address?
While Enhanced Recovery After Surgery (ERAS) protocols have proven beneficial for open liver resections, their effectiveness in the context of laparoscopic liver resection remained unclear. Laparoscopic surgery, being less invasive, might intuitively lead to faster recovery, but the specific impact of a structured ERAS program on this patient population needed empirical validation. The authors aimed to fill this gap by comparing outcomes between patients undergoing laparoscopic hepatectomy with and without an ERAS protocol.
Methods
The study employed a comparative observational design. Two groups of patients undergoing laparoscopic liver resection at the same hospital were compared: an ERAS group (80 patients) and a control group (107 patients) receiving conventional perioperative care. The ERAS protocol involved a multi-faceted approach including:
- Preoperative: Detailed patient education, carbohydrate loading 2 hours before surgery, and no routine bowel preparation.
- Intraoperative: Maintaining room temperature above 25°C, using warm air blowers, minimizing nasogastric tubes and abdominal drains, and restricting intravenous fluids.
- Postoperative: Early oral intake (liquids 6 hours post-surgery, progressing to semiliquid and then normal diet), early mobilization (walking on postoperative day 1), early removal of urinary catheters and abdominal drains, and multimodal pain management (patient-controlled intravenous analgesia with parecoxib and oral tramadol/celecoxib as needed).
The control group received standard care, which included routine bowel preparation, nasogastric tubes, and delayed oral intake and mobilization.
Datasets
Not discussed in the paper. The study utilized patient data collected during their hospitalization and at a 30-day follow-up.
Key Insights and Ideas
- ERAS is more than just "less invasive": While laparoscopic surgery is inherently less invasive, the structured approach of ERAS amplifies these benefits by actively promoting early recovery through a combination of optimized nutrition, pain management, and mobilization.
- Multimodal pain management is key: The study highlights the success of a multimodal pain management strategy (local anesthesia, IV PCA, oral analgesics) in achieving good pain control without relying on potentially more invasive methods like epidural analgesia, which can increase complication risks.
- Early mobilization is critical: Encouraging patients to walk on postoperative day 1, facilitated by early drain removal and good pain control, was a significant factor in reducing complications like deep vein thrombosis (DVT).
- Teamwork makes the dream work: The authors emphasize the importance of a professional and united team (doctors, anesthetists, nurses, pharmacists) in successfully implementing and maintaining an ERAS program.
Key Results
The ERAS group demonstrated significantly better outcomes across several key metrics:
- Hospital Stay: Median postoperative hospital stay was 6.2 ± 2.6 days in the ERAS group, compared to 9.9 ± 5.9 days in the control group (P < 0.001).
- Hospitalization Cost: The ERAS group incurred lower costs ($6871 ± 2571) than the control group ($7948 ± 3630) (P = 0.020).
- Complications: The overall morbidity rate was significantly lower in the ERAS group (22.5%) compared to the control group (43.9%) (P = 0.002). Specifically, DVT occurred in no ERAS patients versus 5.6% in the control group (P = 0.030). More severe complications (Grade II-V) were also less frequent in the ERAS group (16.3% vs. 30.8%, P = 0.020).
- Pain Scores: Pain scores were significantly lower in the ERAS group on postoperative days 1, 3, and 5 (P < 0.001 for all).
- Functional Recovery: Time to functional recovery was also shorter in the ERAS group (5.0 ± 2.3 days) compared to the control group (8.5 ± 4.4 days) (P < 0.001).
- Readmission: No significant difference was found in readmission rates between the two groups.
Limitations and Future Work
The authors acknowledge that their study was a retrospective comparison. While they aimed for effective and safe measures, a randomized controlled trial (RCT) would provide stronger evidence. They are currently conducting such a trial (NCT02533193). Future work should continue to explore the optimal components of ERAS protocols for various surgical procedures and patient populations, with a focus on long-term outcomes and cost-effectiveness. The study also suggests that more research is needed on the specific application of ERAS in laparoscopic hepatectomy, especially with randomized prospective studies.
Summary updated